Rotavirus vaccines must perform in low-income countries too

Lancet

Volumn 370, Issue 9601, 2007, Pages 1739-1740

  Grimwood, Keith ^a   Bines, Julie E ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

AFRICA; ARTICLE; ASIA; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; EUROPE; GASTROENTERITIS; HOSPITAL ADMISSION; HUMAN; IMMUNITY; IMMUNIZATION; INTUSSUSCEPTION; LOWEST INCOME GROUP; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; ROTAVIRUS; SOUTH AND CENTRAL AMERICA; VIRUS CLASSIFICATION; VIRUS INFECTION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

EID: 36249009140     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61730-9     Document Type: Note

References (12)

1. Lepage P. Rotavirus infection in Europe: time for effective prevention?. Pediatr Infect Dis 25 suppl 1 (2006) S5-S6
2. Vesikari T., Karvonen A., Prymula R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370 (2007) 1757-1763
3. Santos N., and Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15 (2005) 29-56
4. Velázquez F., Matson D., Calva J., et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335 (1996) 1022-1028
5. Ruiz-Palacios G., Pérez-Schael I., Velázquez F., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 (2006) 11-22
6. Vesikari T., Matson D., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 (2006) 23-33
7. Parashar U., Gibson C., Bresee J., and Glass R. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12 (2006) 304-306
8. Cunliffe N., Kilgore P., Bresee J., et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ 76 (1998) 525-537
9. Gentsch J., Laird A., Bielfelt B., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192 suppl 1 (2005) S146-S159
10. Glass R., Parahar U., Bresee J., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 (2006) 323-332
11. Simonsen L., Viboud C., Elixhauser A., Taylor R., and Kapikian A. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 192 suppl 1 (2005) S36-S43
12. Vesikari T., Karvonen A., Forrest B., Hoshino Y., Chanock R., and Kapikian A. Neonatal administration of rhesus rotavirus tetravalent vaccine. Pediatr Infect Dis J 25 (2006) 118-122